Search

everythinglearnresearchcommunity

for

Search:↓

Long-term use of dutasteride for enlarged prostate may worsen blood sugar, cholesterol, and erectile dysfunction.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Finasteride worsens erectile dysfunction and lowers testosterone in men with enlarged prostates, unlike tamsulosin.

Finasteride may increase erectile dysfunction risk in patients with benign prostatic hyperplasia.

Higher DHT levels are linked to fewer hypogonadism symptoms in men with normal testosterone levels.

Finasteride works best in 6 months and lasts 6 years.

Tadalafil is effective for treating urinary symptoms in men with BPH.

Taking tadalafil and finasteride together is safe and effective for treating urinary symptoms and erectile dysfunction in men with enlarged prostates.

Finasteride side effects in young men may be linked to specific gene variations.

Post-finasteride Syndrome causes lasting negative effects, but more research is needed for treatment and risk evaluation.

Finasteride caused long-term sexual and non-sexual side effects in young men with hair loss.

More men are getting benign prostatic hyperplasia, and there are many treatments, from medication to surgery, with new methods being developed.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

5α-Reductase inhibitors do not consistently increase testosterone levels in the blood.

5-alpha-reductase inhibitors help treat urinary symptoms from an enlarged prostate.

Blood tests are needed to confirm high male hormone levels in women with PCOS, as physical signs alone are not reliable.

Finasteride treats enlarged prostate and baldness, but may cause limited urinary improvement and sex-related side effects.

Finasteride can cause sexual problems and depression in young men.

Dutasteride is effective for treating prostate enlargement and reducing related surgery risk, but is not approved for preventing prostate cancer.

Finasteride treats enlarged prostate, shrinks it, improves urination, but may cause sexual dysfunction and isn't for women or children.

Testosterone significantly affects sexual desire in both men and women, but its impact on women is more complex and influenced by psychological factors.

Nearly half of the studied men with long COVID had low testosterone, including younger men.

5α-reductase inhibitors may worsen sexual drive and spontaneous erections but don't worsen existing erectile or ejaculatory problems.

Men with low testosterone should be carefully evaluated and monitored before and during treatment.

Testosterone treatment for older men can have short-term benefits, but long-term risks are unclear, requiring careful evaluation and monitoring.

More high-quality research is needed to recommend flavonoids and saponins for clinical use.

Testosterone replacement therapy helps manage deficiency and has various methods, but requires careful monitoring to avoid side effects.

Post-finasteride syndrome's existence is uncertain; more research needed.

Dutasteride effectively treats benign prostatic obstruction, improves urinary flow, reduces prostate size, and may prevent prostate cancer, but can cause sexual side effects.

New treatments for enlarged prostate are being developed to be more effective and have fewer side effects.